Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Invested Capital (2016 - 2025)

Historic Invested Capital for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to $13.7 million.

  • Fennec Pharmaceuticals' Invested Capital fell 4476.62% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 4476.62%. This contributed to the annual value of $12.3 million for FY2024, which is 3288.71% down from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Invested Capital stood at $13.7 million, which was down 4476.62% from $10.7 million recorded in Q2 2025.
  • Fennec Pharmaceuticals' Invested Capital's 5-year high stood at $34.6 million during Q3 2023, with a 5-year trough of $2.8 million in Q3 2022.
  • Moreover, its 5-year median value for Invested Capital was $18.0 million (2023), whereas its average is $19.2 million.
  • Per our database at Business Quant, Fennec Pharmaceuticals' Invested Capital plummeted by 8833.13% in 2022 and then surged by 113415.42% in 2023.
  • Fennec Pharmaceuticals' Invested Capital (Quarter) stood at $24.0 million in 2021, then fell by 6.59% to $22.4 million in 2022, then decreased by 18.07% to $18.4 million in 2023, then crashed by 32.89% to $12.3 million in 2024, then rose by 11.19% to $13.7 million in 2025.
  • Its last three reported values are $13.7 million in Q3 2025, $10.7 million for Q2 2025, and $12.3 million during Q1 2025.